Servando Hernandez Vargas

9PUBLICATIONS
21CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 27, 2025
RBM39 Contributes to MGMT Maintenance in Response to Temozolomide-Induced DNA Damage.

Vahid Khalaj, Jack T Adams, Solmaz AghaAmiri

|Sep 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications.

Servando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams

|Jan 25, 2025
SSTR2-Targeted Theranostics in Hepatocellular Carcinoma.

Majid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas

|Feb 12, 2024
Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide.

Solmaz AghaAmiri, Sukhen C Ghosh, Servando Hernandez Vargas

|Sep 29, 2022
High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery.

Servando Hernandez Vargas, Solmaz AghaAmiri, Sukhen C Ghosh

Pageof 2